Microglia and the immune pathology of Alzheimer disease
Microglia and the immune pathology of Alzheimer disease
复制标题
DOI:
10.1086/302477
复制
发表时间:
1999-07-01
影响因子:
9.8
通讯作者:
Giulian, D
中科院分区:
文献类型:
--
作者:
Giulian, D
Alzheimer disease (AD) is a chronic degenerative disorder of the brain, which accounts for the most common form of dementia in the elderly. During the past decade, much effort has been devoted to the delineation of mechanisms of this disease and to the search for new treatment strategies. The histopathology of AD is well established, with hallmarks including senile plaque (complex protein aggregates containing the b-amyloid peptide [Ab]), neuritic tangles (remnants of neurons containing hyperphosphorylated t protein), loss of neurons, damaged synaptic connections, and reactive gliosis. Reactive gliosis involves both microglia, which attack the senile plaque (fig. 1), and astroglia, which surround the plaque complex as a protective wrap. Views concerning the pathogenesis of dementia have evolved significantly during the past few years. It is generally agreed that abnormalities of Ab metabolism are critical for the development of AD (Selkoe 1993). Epidemiology, coupled with biochemical studies, has identified mutations within Ab-precursor protein (APP) as causal factors for familial forms of AD, whereas isoforms of apolipoprotein E (apo E) have been identified as risk factors for sporadic disease (Selkoe 1993; Strittmatter et al. 1993; Price et al. 1998; Growdon 1999). Moreover, intracellular aspects of dementia have received much attention, since abnormalities in presenilin appear to affect processing of APP and production of Ab (Kovacs and Tanzi 1998; Sisodia et al. 1999 [in this issue]). Regardless of initiating events for the disease, it is recognized that neuronal and synaptic damages are responsible for loss of cognitive function in AD. What remain uncertain are the events that link Ab metabolism with loss of neurons. Many disease pathways contributing to AD pathology have been proposed; the role of the brain immune cell, the microglia, is considered here.